Symphony Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Symphony Asset Management's MDT Position: Q1 2020 in Review
Symphony Asset Management sold out of Medtronic (MDT) in Q1 2020, closing a stake of 10,739 shares — an estimated $1.22M sold.
Symphony Asset Management first reported a position in MDT in Q2 2013 and held it in 20 quarters. The position peaked at $3.59M in Q4 2017. 1,762 funds tracked by Wall St. Rank hold MDT as of Q1 2020.
- Symphony Asset Management reported no remaining Medtronic position as of Q1 2020 after selling out during the quarter.
- Symphony Asset Management sold 10,739 Medtronic shares in Q1 2020, an estimated $1.22M.
- Symphony Asset Management first reported a position in Medtronic in Q2 2013 and held it in 20 quarters.
- Symphony Asset Management's Medtronic position peaked at $3.59M in Q4 2017.
- 1,762 funds tracked by Wall St. Rank held Medtronic as of Q1 2020.
Based on Symphony Asset Management's 13F filing for Q1 2020, filed 12 May 2020.